the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

One per cent PWD employment policy being reviewed – Dr Zaliha

KUALA LUMPUR: The one per cent employment of Persons with Disabilities (PWD) policy in the public service is currently under review to enhance its implementation, the Dewan Rakyat was told today.

Minister in the Prime Minister’s Department (Federal Territories) Dr Zaliha Mustafa said this is because, since 2014, the policy has still not achieved its target.

“One of the identified reasons is the low number of job applications from PWD candidates, which is less than one per cent of the overall applicant pool.

“In the Job Satisfaction Survey Among PWD Civil Servants, it was found that among the main challenges faced by this group are their abilities and competencies, stressed by job demands within their limitations, as well as the support and facilities they require,” she said during the question and answer session.

She was responding to a question from Datuk Seri Dr Shahidan Kassim (PN-Arau), who wanted to know about the latest 10-year statistics on the percentage of PWD civil servants since the introduction of the policy.

Dr Zaliha said, however, the statistics indicated an increase over the years, with 0.23 per cent in 2014, 0.25 per cent (2015), 0.28 per cent (2016), 0.29 per cent (2017 to 2022) and 0.3 per cent (2023).

In response to a suggestion from Lim Lip Eng (PH-Kepong) to increase the number of PWD civil servants at Kuala Lumpur City Hall, Dr Zaliha highlighted the notable progress in filling PWD positions in the Federal Territories, including in that local authority, which stood at 0.5 per cent from over 10,000 people.

“As for the proposal to increase PWD civil servants in Parliament, I support that proposal as an effort to further enhance the employment of PWDs in the public sector,” she said. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings